| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6827001 | Schizophrenia Research | 2012 | 6 Pages |
Abstract
We obtained no evidence of altered CSF oxytocin levels in patients with schizophrenia or those with MDD. However, lower oxytocin levels may be related to higher second generation antipsychotic dose and more severe negative symptoms in schizophrenia.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Daimei Sasayama, Kotaro Hattori, Toshiya Teraishi, Hiroaki Hori, Miho Ota, Sumiko Yoshida, Kunimasa Arima, Teruhiko Higuchi, Naoji Amano, Hiroshi Kunugi,